統合失調症の治療に光、待望の新しい抗精神病薬は“希望”になるか
wired,
それは1951年12月11日のことだった。フランスの製薬会社であるローヌ・プーランの研究室で、化学者ポール・シャルパンティエがひとつの薬剤を完成させた。この薬が、のちの精神医学の世界を大きく変えることになる。 シャルパンティエは革命を起こそうなどとは考えてい…
それは1951年12月11日のことだった。フランスの製薬会社であるローヌ・プーランの研究室で、化学者ポール・シャルパンティエがひとつの薬剤を完成させた。この薬が、のちの精神医学の世界を大きく変えることになる。 シャルパンティエは革命を起こそうなどとは考えてい…
On December 11, 1951, in the labs of French pharmaceutical company Rhône-Poulenc, chemist Paul Charpentier concocted a drug…
On December 11, 1951, in the labs of French pharmaceutical company Rhône-Poulenc, chemist Paul Charpentier concocted a drug…
Current antipsychotics are plagued by patchy efficacy and unwanted side effects—but a new treatment could change all that.
People living with serious mental illness (SMI) are at higher risk for a wide range of chronic physical conditions1, are more…
This article is sponsored by Teva Pharmaceuticals. Recently a panel of psychiatrists, nurse practitioners, people living with…
I n the wake of back-to-back mass shootings in El Paso and Texas last month, President Trump stated that millions of Americans…
PERSERIS is the only subcutaneous risperidone-containing long-acting injectable available in the United States SLOUGH, England…
SOURCE Indivior PLC PERSERIS is the only subcutaneous risperidone-containing long-acting injectable available in the United…
SLOUGH, England and RICHMOND, Va., Feb. 27, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the launch of once-mont…
SOURCE Indivior PLC PERSERIS is the only subcutaneous risperidone-containing long-acting injectable available in the United…
SOURCE Indivior PLC PERSERIS is the only subcutaneous risperidone-containing long-acting injectable available in the United…
PERSERIS is the only subcutaneous risperidone-containing long-acting injectable available in the United States SLOUGH, England…
SLOUGH, England and RICHMOND, Va., Feb. 27, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the launch of once-mont…
SOURCE Indivior PLC PERSERIS is the only subcutaneous risperidone-containing long-acting injectable available in the United…
Indivior PLC (LON: INDV) today announced the launch of once-monthly PERSERIS™ (risperidone) for extended-release injectable…
SOURCE Indivior PLC PERSERIS is the only subcutaneous risperidone-containing long-acting injectable available in the United…
PR Newswire SLOUGH, England and RICHMOND, Va., Feb. 27, 2019 SLOUGH, England and RICHMOND, Va.
SLOUGH, England and RICHMOND, Va., Feb. 27, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the launch of once-mont…
PERSERIS is the only subcutaneous risperidone-containing long-acting injectable available in the United States SLOUGH, England…
SLOUGH, England and RICHMOND, Va., Feb. 27, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the launch of once-mont…